PDND
Phytochemical Database for Neurological Disorders
search icon
Advanced search

Phytochemical Name : Letrozole
PCNDIDL0034
Pubchem CID : 3902
Molecular formula: C17H11N5

Molecular weight : 285.300

Canonical SMILES : C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3

Synonymes : letrozole|112809-51-5|Femara|4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile|Letrozol|CGS 20267|CGS-20267|Letoval|4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile|C17H11N5|LETRAZOLE|Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-|Femera|4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile|Letrozole [USAN:INN]|4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile|Femara (TN)|HSDB 7461|4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile|NSC-759652|CHEMBL1444|Letrozole (JAN/USP/INN)|UNII-7LKK855W8I|4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE|4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile|7LKK855W8I|CCRIS 8822|CHEBI:6413|DTXSID4023202|1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole|FEM-345|Letrozole [USAN:USP:INN:BAN]|LEROZOLE|4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile|NCGC00016973-01|CAS-112809-51-5|1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole|DTXCID503202|SMR000466343|SR-01000759382|Femara, Letrozole|Letrozole- Bio-X|CGS20267|MFCD00866241|LETROZOLE [INN]|LETROZOLE [JAN]|LETROZOLE [MI]|LETROZOLE [HSDB]|LETROZOLE [USAN]|Prestwick0_001025|Prestwick1_001025|Prestwick2_001025|Prestwick3_001025|Femara (TN) (Novartis)|D0C1WH|LETROZOLE [MART.]|LETROZOLE [USP-RS]|LETROZOLE [WHO-DD]|Novartis Brand of Letrozole|SCHEMBL4331|BIDD:PXR0130|BSPBio_001209|MLS000759455|MLS001424038|MLS002584991|MLS006010040|BIDD:GT0015|SPBio_003070|BPBio1_001331|GTPL5209|LETROZOLE [EP IMPURITY]|LETROZOLE [ORANGE BOOK]|LETROZOLE [EP MONOGRAPH]|Letrozole, >=98% (HPLC)|BDBM13061|EX-A965|LETROZOLE [USP MONOGRAPH]|4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)|HMS1571M11|HMS2051E08|HMS2089L22|HMS2098M11|HMS2233C23|HMS3369E11|HMS3393E08|HMS3651K05|HMS3715M11|Pharmakon1600-01502354|AMY32541|BCP23354|Tox21_110719|Tox21_303572|4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole|NSC719345|NSC759652|s1235|STL451047|AKOS005145822|AB07525|AC-1193|BCP9000848|C17-H11-N5|CCG-100849|CS-1776|DB01006|KS-1269|NC00099|NSC 759652|NSC-719345|NCGC00016973-02|NCGC00016973-03|NCGC00016973-06|NCGC00257460-01|BL164620|HY-14248|LS-38788|BCP0726000213|CGS 20267, Femara, Piroxicam, Letrozole|1-Bis(4-cyanophenyl)methyl-1,2,4-triazole|4,2,4-Triazol-1-ylmethylene)dibenzonitrile|AB00514009|L0248|SW197294-4|A25380|C08163|D00964|EN300-264820|AB00514009-05|AB00514009-07|AB00514009-08|AB00514009-09|AB00514009_10|AB00514009_11|KISQALI FEMARA CO-PACK COMPONENT LETROZOLE|Q194974|W-60273|4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile|LETROZOLE COMPONENT OF KISQALI FEMARA CO-PACK|Q-201291|SR-01000759382-4|SR-01000759382-5|BRD-K88789588-001-03-2|4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile|4,4'-(1h-1,2,4-triazol-1-ylmethylene)-bisbenzonitrile|F2173-0288|Z1741968261|4,4'-((1H-1,2,4-Triazol-1-yl)-methylene)dibenzonitrile|Letrozole, European Pharmacopoeia (EP) Reference Standard|Letrozole, United States Pharmacopeia (USP) Reference Standard|4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE|Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material

Structure
3D structure 2D structure
3902
Predicted properties (NCBI Pubchem)

Physicochemical Properties